Back to search

Belgium· BE-AMP-SAM198256-00

Lipanthyl 67 Micronised 67 mg

A fenofibrate product containing fenofibrate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 15 of our 19 countries.

ATC C10AB05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedLipanthyl 67 Micronised 67 mgATCC10AB05REGISTER NO.BE-AMP-SAM198256-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Fenofibrate is registered in 15 of 19 countries.

Countries holding a registration under ATC C10AB05 (fenofibrate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 10 of them publish a price we can compare per daily dose

Fenofibrate · ATC C10AB05

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of fenofibrate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.22 in Spain to $1.30 in United States — a ×5.8 gap.

  • 5 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail

Fenofibrate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • US United States$1.30 (acquisition cost)
  • CH Switzerland$0.75
  • IT Italy$0.35
  • FR France$0.24
  • ES Spain$0.22
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fenofibrate
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
C10AB05
ATC class
Fenofibrate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    1440585
    EUR 11.64
  • be_apb
    0766808

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

268 interactions on record for fenofibrate.

Graded by severity as the source publishes them — 10 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Fenofibrate · interactions on record

268 records

  • 10 severe
  • 75 moderate
  • 183 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • SimvastatinC10AA01severe
  • RosuvastatinC10AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fenofibrate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fenofibrate products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Fenolip Retard, Lipcor
  • Bulgaria · Липантил, Липантил Супра
  • Cyprus · Lipidil Nt
  • Czechia · Fenofix, Fortilip
  • Germany · Cil, Elipsia
  • Estonia · Lipanthyl
  • Spain · Fenofibrate Teva, Fenofibrato Aurovitas
  • Finland · Lipanthyl Penta
  • France · Fegenor, Fenofibrate Almus
  • United Kingdom (Northern Ireland) · Fenofibrate, Fenofibrate Accord Uk
  • Greece · Fenobrat, Lipidil Nt
  • Croatia · Fenolip, Tricor
  • Hungary · Fenobrat, Fenoswiss
  • Ireland · Lipantil Micro, Lipantil Supra
  • Italy · Fenofibrato Aurobindo, Fenofibrato Eg
  • Lithuania · Lipanthyl
  • Luxembourg · Fenofibraat Eg, Fenogal Lidose
  • Latvia · Lipanthyl
  • Malta · Lipantil Supra
  • Netherlands · Fenogal
  • Norway · Thylip
  • Poland · Biofibrat, Fenardin
  • Portugal · Catalip, Catalip Micronizado
  • Romania · Fenofibrat Terapia, Lipanthyl Supra
  • Sweden · Lipanthyl, Thylip
  • Slovenia · Katalip
  • Slovakia · Fenofibrate Teva, Fenofix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4fb66ec9-d46f-46d8-b5d7-e09e49eda706
GET /v1/drugs/4fb66ec9-d46f-46d8-b5d7-e09e49eda706?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Lipanthyl 67 Micronised 67 mg",
  "name_fr": "Lipanthyl 67 Micronised 67 mg",
  "name_nl": "Lipanthyl 67 Micronised 67 mg",
  "amp_code": "SAM198256-00",
  "strengths": [
    "67.0000",
    "67.0000",
    "33.8000",
    "2.4000"
  ],
  "pack_count": 2,
  "substances": [
    "Fenofibrate",
    "Lactose",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fenofibrate",
  "authorisation_numbers": [
    "BE198256"
  ]
}

See everything about fenofibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.